Methods |
Patients randomized into two groups, comparing artificial rupture of membranes and intravenous oxytocin with vaginal prostaglandin. |
Participants |
Participants: 50.
Inclusion criteria: Primiparous as well as multiparous women; gestational age more than 36 weeks; alive fetus.
Exclusion criteria: not mentioned. |
Interventions |
Intervention 1: PG E2 vaginal gel, 1 mg administered vaginally and repeated in 6 hours (dose 1‐2 mg, depending on previous response).
Intervention 2: Amniotomy and intravenous oxytocin, amniotomy was performed within 30 minutes after starting the oxytocin infusion (starting dose 2 mU/min; maximum dose 30 mU/min). |
Outcomes |
Included outcomes: Caesarean section; serious neonatal morbidity/perinatal death; uterine hyperstimulation without FHR changes; epidural analgesia; instrumental vaginal delivery; Apgar score < 8 at 5 minutes. |
Notes |
French study. |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Allocation concealment? |
Unclear risk |
B ‐ Unclear |